The outbreak of Covid-19 is not going that well with those suffering from Alzheimer’s disease. Due to memory loss, adhering to a routine is imperative. However, the ongoing pandemic has disturbed the routine of almost everyone. Alzheimer’s-infected people do have a devastating experience, as their routine, in the normal course, needs to be catered to by caretaker (s). With Covid-19 on the table, Both – the caretaker and patient need to be doubly careful as both are at equal risk of contracting Covid-19. These factors are expected to accelerate have been accelerating the Alzheimer’s disease therapeutics market since Mar 2020 as healthcare personnel are trying their best to keep Alzheimer’s under check, so that protection against Covid-19...
The ongoing pandemic has thrown almost the entire world out of gear. The ones suffering from chronic ailments like cancer need to be extra careful as they are more prone to contracting Covid-19. Still, it wouldn’t be incorrect to state that the Adrenocortical Carcinoma treatment market is unfazed by Covid-19, as very few people contract Adrenocortical Carcinoma. So, even if the vaccine against Covid-19 surfaces mid-2021, the market’s situation would be more or less – the same (except a few alterations in North America due to somewhat more number of people getting Adrenocortical Carcinoma).